Vertex Pharmaceuticals Incorporated shares owned by Lawrence Kelly & Associates, Incorporated
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Lawrence Kelly & Associates, Incorporated
from 13F filings
Historical chart of Lawrence Kelly & Associates, Incorporated investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Lawrence Kelly & Associates, Incorporated consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Lawrence Kelly & Associates, Incorporated
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $281k | 605 | 465.08 |
| 2024-06-30 | $612k | 1.3k | 468.72 |
| 2024-03-31 | $610k | 1.5k | 418.01 |
| 2023-09-30 | $511k | 1.5k | 347.74 |
| 2023-06-30 | $503k | 1.5k | 342.69 |
| 2023-03-31 | $463k | 1.5k | 315.07 |
| 2022-12-31 | $464k | 1.6k | 288.78 |
| 2022-09-30 | $611k | 2.1k | 289.65 |
| 2022-06-30 | $594k | 2.1k | 281.94 |
| 2022-03-31 | $550k | 2.1k | 261.01 |
| 2021-12-31 | $468k | 2.1k | 219.83 |
| 2021-09-30 | $385k | 2.1k | 181.03 |
| 2021-06-30 | $429k | 2.1k | 201.51 |
| 2021-03-31 | $456k | 2.1k | 214.44 |
| 2020-12-31 | $186k | 787 | 236.34 |
| 2020-09-30 | $694k | 2.6k | 271.99 |
| 2020-06-30 | $735k | 2.5k | 290.32 |
| 2020-03-31 | $1.8M | 7.7k | 238.02 |
| 2019-12-31 | $1.8M | 8.3k | 218.89 |
| 2019-09-30 | $1.5M | 8.8k | 169.44 |
| 2019-06-30 | $1.7M | 9.0k | 183.33 |
| 2019-03-31 | $1.8M | 9.8k | 184.00 |
| 2018-12-31 | $1.9M | 11k | 165.68 |
| 2018-09-30 | $2.2M | 11k | 192.73 |
| 2018-06-30 | $2.0M | 12k | 169.99 |
| 2018-03-31 | $2.2M | 13k | 162.94 |
| 2017-12-31 | $3.0M | 20k | 149.89 |
| 2017-09-30 | $3.1M | 21k | 152.07 |
| 2017-06-30 | $2.7M | 21k | 128.90 |
| 2017-03-31 | $2.3M | 21k | 109.33 |
| 2016-12-31 | $1.6M | 21k | 73.68 |
| 2016-09-30 | $8.6M | 98k | 87.21 |
| 2016-06-30 | $8.4M | 98k | 86.02 |
More positions owned by Lawrence Kelly & Associates, Incorporated
View all positions for Lawrence Kelly & Associates, Incorporated
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated